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Abstract
The SARS-CoV-2 global pandemic will disproportionately impact countries with weak
economies and vulnerable populations including people with dementia. Latin American
and Caribbean countries (LACs) are burdened with unstable economic development,
fragile health systems, massive economic disparities, and a high prevalence of dementia. Here, we underscore the selective impact of SARS-CoV-2 on dementia among
LACs, the specific strain on health systems devoted to dementia, and the subsequent
effect of increasing inequalities among those with dementia in the region. Implementation of best practices for mitigation and containment faces particularly steep
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challenges in LACs. Based upon our consideration of these issues, we urgently call for
a coordinated action plan, including the development of inexpensive mass testing and
multilevel regional coordination for dementia care and related actions. Brain health
diplomacy should lead to a shared and escalated response across the region, coordinating leadership, and triangulation between governments and international multilateral
networks.
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1
WHY LATIN AMERICA REQUIRES A
REGIONAL STRATEGY

America and Caribbean countries (LACs) now face an extremely challenging situation. LACs remains a hot spot of the disease, and available data show similar upward slopes of deaths in LACs similar to those

The brunt of the SARS-CoV-2 pandemic is hitting the aged and pardisadvantaged.1

in North America, Europe, or Asia (Figure 1). LACs have a reproduc-

Often neglected is the dev-

tion number (R) greater than one8 meaning that the number of cases

astating impact of COVID-19 for individuals with dementia and for

is growing exponentially. In addition, there is a fundamental lack of

their caregivers.2,3 Across the world, while every age group is sus-

preparedness to deal with the pandemic.9 We have recently raised

ticularly those who are

ceptible to SARS-CoV-2 infection, older adults suffer a much higher

awareness of the critical influence in LACs’ dementia patients.2 Beyond

mortality with the disease. As health systems become overwhelmed,

awareness, the situation requires an adequate response across the

access to dementia programs is becoming even more restricted. Imple-

region that can coordinate our approaches for the dementia popula-

menting physical distancing in people with dementia is difficult.3 The

tion. Here, collaborators from LACs and beyond first explore these

combination of reduced work and quarantine can greatly disrupt fam-

specific regional impacts and then urgently call for a collaborative

ily dynamics. Dementia-associated comorbidities such as hyperten-

response to anticipate the upcoming challenges.

sion, diabetes, cardiovascular disease, and cerebrovascular disease all
impact SARS-CoV-2 severity.4 Central nervous system deficits such
as smell and taste impairments and even hallucinations have been
observed in association with COVID-195,6 and rates of delirium are

2
THE PANDEMIC THREATENS THE COLLAPSE
OF HEALTH SYSTEMS ACROSS LACs

high in elders in intensive care units (ICU), particularly for those on
a ventilator. Inflammatory responses elicited by infection may trig-

Health care in the region was already precarious before the pandemic

ger long-term mechanisms of neurodegeneration.7 For example, a still

with a per capita expenditure of $949 a year,10 (only one quarter of

poorly understood condition linked with the 1918 flu pandemic is

the average rate for countries of the Organization for Economic Co-

post-encephalitic Parkinsonism, with degeneration of the substantia

operation and Development [OECD]). Further, in LACs expenditures

nigra and the presence of neurofibrillary tangles but without senile

are highly dependent on self-payment (LACs’ average = 34% of total

plaques. The long-term consequences of COVID-19 remain completely

health spending, OECD average = 21%). Universal health needs are

unknown, although our centers are beginning to see post-COVID

uncovered by insurance services, with unequal distribution between

patients with cognitive complaints.

rural/urban areas and public/private services. About 30% of the LACs’

Clearly, the coronavirus compromises dementia patients;3 how-

population lacks regular access to health services and the number of

ever, the impact is not equally distributed across the population. Here

hospital beds is small (2.7 per 1000 inhabitants, with a very small por-

we describe that patients, families, and health professionals in Latin

tion of intensive care beds,10 compared to the OECD average of 4.7).
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Heterogeneity and fragmentation characterize the health systems
specialized for dementia across LACs, with few available mechanisms

RESEARCH IN CONTEXT

for coordination among governmental and private providers. Countries
with stronger public health systems can develop specific responses.
Mexico implemented an epidemiological surveillance system that
receives feedback from medical centers, and Chile has recently developed pilot care centers in primary and specialized care centers in the
public sector enabling remote care during the outbreak, even when
coverage is

limited.11

Cuba has also bet on its primary care system to

proactively detect coronavirus cases in the population through general
screening questionnaires and contact tracing.12 In Uruguay, to date,
the coronavirus has been well controlled. By contrast, most of the other
countries do not have specific resources for the pandemic, and have
important barriers to care, particularly in rural areas and among poorer
urban populations. According to the Pan-American Health Organization (PAHO),13

the LACs will fail to provide basic responses to the pan-

demic including (1) widespread and massive testing with active isolation, (2) intensive and intermediate care units, (3) ventilators and
supplementary oxygen by nasal cannula, (4) access to pharmacological
treatments, and (5) guaranteed protection for health workers. On the
horizon, we are also concerned about future access to a vaccine once

1. Systematic review: The authors reviewed the literature
using traditional sources (eg, PubMed). The unique critical situation for dementia patients in Latin America and
the Caribbean countries (LACs) in the coronavirus era
is reviewed. Other imperative calls for awareness of
COVID-19’s impact on dementia have been raised at a
global level, as well as the unique influence of pandemic
on LACs’ health. However, no previous work has proposed
a coordinated response to the LACs’ selective impact on
dementia patients yet.
2. Interpretation: We review the current situation of
dementia patients across LACs under the pandemic. Then
we present recommendations for a coordinated action
plan. Collaborators from LACs and beyond first explore
these specific regional impacts and then urgently call
for a collaborative response to anticipate the upcoming
challenges.
3. Future directions: We propose specific actions and a
regional brain health diplomacy framework to coordinate

one becomes available.
By 2050, the prevalence of dementia across LACs will increase

urgent responses for the dementia population.

four-fold, and patients from LACs suffer reduced social and healthcare access.14 The pandemic is already impacting these people (see
Box 1 for testimonies from across the region) and most countries
are not ready to provide the necessary support to deliver social and

Limited telemedicine capabilities, as well as restricted access to the

hospitals15

Internet in the region create additional complications for dementia

involves a significant deficit of care for non–coronavirus-related

care. Although telemedicine cannot replace face-to-face care, it is an

diseases, such as dementia. A regional lack of sufficient numbers

extremely important tool in pandemic times,22 in particular to sup-

of ventilators will raise painful moral dilemmas for decision making

port the care of dementia patients.23 However, many LAC hospitals

regarding patients with dementia. Most public clinics have cancelled

do not provide virtual consultation or medical prescription with a dig-

patients’ appointments to make room to attend the pandemic, so there

ital signature.24 As reported by some of the co-authors of this report

are few physicians to receive those dementia patients needing medical

working in hospitals, in specific areas of Argentina, Brazil, Colom-

attention.

bia, Ecuador, Dominican Republic, and Peru, many patients cannot be

residential care. The large drop in consultation rate in

The LACs’ high prevalence of noncommunicable

diseases16

across

reached by telephone or e-mail. In Brazil, most dementia consultations

vulnerable dementia patients will worsen COVID-19 health com-

in the public health system are in person, with neither telemedicine

plications. Conditions such as hypertension, cardiovascular disease,

nor remote consultation. Approximately 40% of hospitals are unable to

and chronic obstructive pulmonary disease all increase mortality

provide remote consultations.25 Web pages, videos, and free demen-

attributed to

COVID-19.17

Cardiovascular diseases (CVD) are a rec-

tia helplines are underused by relatives of dementia patients. Barriers

ognized risk factor for dementia in LACs.18 Almost half of COVID-

include geographic and economic conditions at remote and rural sites

19 patients who have been hospitalized show scan abnormalities that

and impoverished urban areas.

resemble the early stages of heart failure.19 The impact that such

The imbalance in access to health systems24 is more severe

interactive effects will have on LACs’ vulnerable older populations is

when considering family dynamics. Formal long-term care (LTC) facil-

unknown. Assisted living facilities and nursing homes have often been

ities are insufficient in the region,26 and deficient for vulnerable

sites with very high rates of infection.20

populations.

Specific co-morbidities in LACs

such as the dengue epidemic that has affected >3 million individu-

Dementia patients often remain with their families even at the

als and caused more than 1500 deaths, mainly in the socioeconomi-

final stages of the disease, providing indirect care. The extended

cally deprived population, has an unknown interaction with COVID-19.

families in LACs with frequent social gatherings that ordinarily cre-

About 500 million people in LACs are at risk of contracting dengue.

ate a protective emotional environment for patients, will become

Overlapping infections and co-occurrence of both diseases increase

dangerous, resulting in further strain due to physical isolation.27

the severity of patients,21 especially in those suffering from dementia

Family caregivers are facing paradoxical challenges regarding care

and related comorbidities.

and the contagious risk of patient contact. Amidst the pandemic
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F I G U R E 1 Patterns of COVID-19 death toll by regions and countries. A, Temporal dynamics of accumulated deaths. The accumulated deaths
for all the countries and regions are shown per day. The slope represents growth rate. A dashed line of 30% growth in each region helps to visualize
the similar growth rate across countries and regions. A gray headset in the top panels of Europe, Latin America, and North America also helps to
identify the time gap in comparison to the start of the COVID-19 outbreak in China. Latin American and Caribben countries (LACs) are in the early
days compared to other regions, although their growth is in line with Europe or North America. B, Exponential growth of confirmed daily deaths by
countries and regions. Rate of change shown as new deaths (per week average) divided by total deaths. In this panel, the new deaths in the past
week are plotted against the total confirmed deaths to date. When plotted in this way, exponential growth is represented as a straight line that
slopes upward. Diagonal slopes indicate exponential growth rate. The rate of change in LACs is exponential. Plots provide a line for each country,
plus a bold line for the regional smooth conditional mean (Loess method). Both panels show how the epidemic started relatively late in LACs.
Despite this, global trajectories of the region suggest similar exponential growth. Data retrieved from Johns Hopkins CSSE
(https://github.com/CSSEGISandData/COVID-19) through https://covid19api.com/ on July 20, 2020. The code for the creation of these plots can
be found in https://github.com/gorkang/2020-coronavirus-LATAM. A daily updated interactive website to explore the data can be found in
https://gorkang.shinyapps.io/2020-coronavirus-LATAM/

and the incumbent social distancing, caregivers will experience
increased burnout syndrome, and dementia patients may face

3
SARS-CoV-2 AMPLIFIES THE INHERENT
INEQUALITIES IN DEMENTIA CARE IN LACs

additional mental health risks and mistreatment.28 Social isolation
will contribute to already prevalent neuropsychiatric symptoms in

According to the World Bank, Latin America is the most unequal

elders, such as depression, distress, loneliness, anxiety, and sedentary

region in the world. LACs host 8 of the 20 most unequal countries in

behavior.

the world, and three quarters of the LAC countries are low or lower-

Finally, health professionals themselves, including neurologists and

middle income. The LAC economic projection for 2020 was initially

mental health workers, are among the vulnerable and their incapac-

pessimistic, and the COVID-19 outbreak has now escalated these

ity reduces the health delivery workforce. Adequate protective equip-

problems. Weak institutional structures for intervention, fractured

ment and medical support for health-care workers is scant across

multinational cooperation, teetering health systems, low economic

LAC.25 Health-care workers suffered an enormous toll in mortality,

growth, poverty, inequality, and unemployment are all precipitating an

and simultaneously weaken the health-care systems in LAC. In Brazil,

unprecedented moment in the region’s history. LACs’ poverty is per-

LTC facilities have shown one of the highest rates of nurses’ deaths,9

vasive (≈185 million needy individuals, 68 million in extreme poverty),

and in Mexico, one fifth of health workers have died.29 Assisted liv-

creating unstable and informal jobs (>50% of the regional population

ing facilities and LTC facilities have often been sites with very high

of workers) and restricting access to sanitation systems and essential

rates of infection20 and are facing critical supply and staff shortages

services (water and sewerage). These overcrowded populations are

in LAC.9 These factors not only increase the burden upon health pro-

forced by SARS-CoV-2 to a double tragedy: should they break the

fessionals, but also the shortage of health-care responses to dementia

quarantine to search for resources and increase the risk of contagion

patients.

for dementia patients or observe the quarantine and fall more deeply
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BOX 1—Voices About Coronavirus from Latin American Countries
We selected particular testimonies across Latin American and Caribbean countries highlighting different dimensions of the coronavirus
outbreak and the impact on dementia patients and families.

Pictures showing four histories and testimonies from Peru: Enrique (top left), Juana (top right), Enedina (bottom left) and Rosita (bottom
right). See below.
Argentina
This country has developed an early, preventive, and compulsory social isolation quarantine, but contagion in overcrowded vulnerable
neighborhoods may still challenge the health system. María Berude, a member of the Argentinean network of physicians said in an open
letter: “We are people who have courage, but we are also afraid of dying. . . . We have uncertainty and anxiety, because we are human
beings. . . . Neither gods, nor heroes, nor murderers, nor mercenaries. Simply medical doctors.”
Brazil
The coronavirus in the largest country in the region has increased exponentially. Jerusa Smid (co-author) summarized the private/public
gap: “I work in a privileged private hospital, they are prepared to amplify the ICU beds from 43 to 280. I also work in a public hospital which
is now out of rooms.” Leonel Takada (co-author) said he was “told to reschedule [dementia patients’] appointments to after June . . . we
couldn’t reach some of them by telephone and we don’t have their email addresses. This puts them into risk of not obtaining prescriptions.”
Chile
In 2019, the Chilean health system incorporated dementia care; however, the pandemic has suspended its implementation. For Andrea
Slachevsky (co-author) “most of dementia patients are taken care by family members at home. Therefore, COVID-19 is imposing a hard
burden on these families”. Claudia Duran (co-author) and basic scientist said: “I had to sacrifice most of my transgenic mice to decrease
the load of work of veterinarians and technicians. . . . Concerning laboratory experiments, all of them are stopped.”
Colombia
In Colombia the response to pandemic encompasses a reduction of care for dementia patients. Alejandra Guerrero (co-author) said that
“in public hospitals the government has implemented actions that impact in patients with dementia, including preventing people above 70
years old from going out, stopping their outpatient consults and leaving them without their prescriptions. Vulnerable populations do not
have internet access for telemedicine or even phone consultation.”
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Cuba
Rather than opting for mitigation, Cuba is a regional exception and has also bet on its primary care system and added a containment plan
(prevention and control). For Juan J. Llibre (co-author), “Medical students, and health workers were mobilized nationwide for door-todoor surveys to identify vulnerable people including people living with dementia and check for symptoms, and roll out a testing program
according to WHO standards. Furthermore, contact tracing and early contact isolation procedures have been imposed on all confirmed
cases.”
Dominican Republic
For Daisy Acosta (co-author) “The Dominican Alzheimer’s Association is cooperating with the department of mental health. Initially, we
knew about the virus but nobody took seriously the protective measures announced. The curfew has been violated by thousands of citizens. As a consequence they have been taken to jail to force them to observe the rules.”
Ecuador
For Myriam de la Cruz (co-author), the pandemic “increases social isolation and diminishes public attention to dementia patients, even
reducing food availability for elders.” A resident of Guayaquil (Carol Neira) commented “Many deceased people and their bodies were
not removed, people do not respect the curfew, and hospitals have not enough capacity for so many infected.” For Lissette Duque (coauthor) “COVID-19 will place our country’s economy in a critical situation. This will probably hit not only the unemployment, but also the
capacity of the public health system to support vulnerable people.” For Gabriel Trueba (University San Francisco Quito) “there are reports
in some indigenous communities, specifically Shushufindi-Cuyabeno, presenting with pneumonia; however, nobody has tested them due
to difficulties reaching them.”
Mexico
The country also struggles with great disparities of a fragmented health care system. For Stefanie Piña (co-author) ,“If a person with
dementia requires treatment for COVID-19, the hospital lacks capacity to prevent hospital-related adverse outcomes. At nursing homes
and in the community, primary and secondary prevention measures are demanding extra effort from caregivers. This is leading to compromised safety for the dyad and to severe caregiver burnout that may end in patient mistreatment.”
Peru
The pictures above illustrates the people’s vulnerabilities and the unpreparedness of the health system. Top left: Enrique (64 years old,
Trujillo) suffers from diabetes mellitus but cannot get medication since two months ago. He is a shoemaker working with a small mobile
stall, and after months of quarantine, he has to go out to work. Top right: Juana (64 years old, Trujillo) is a merchant diagnosed with coronavirus 3 months ago, which led to her needing supplemental oxygen and intravenous medications. Given the collapse of the hospitals,
she was treated at home by her daughter. She said the thought might lose her life, unable to perform simple activities (such as walking
and eating) without great efforts. Now she is recovering. Bottom left: Enedina (65 years old, Lima) lives with her youngest son who lost
his job due to the pandemic restrictions. They live in a precarious room, without electricity, water, or drainage. Bottom right: On the other
side of Lima, 83-year-old Mrs. Rosita lives with her family in a wealthy district. Her daughter has noted typical dementia symptoms, which
exacerbated since the quarantine. She doesn’t understand the isolation, needs constant monitoring, and urgently requires a neurological
evaluation, but there are no services available due to the pandemic.
Photos and testimonies from Peru documented by Alexander Kornhuber and Maritza Pintado Caipa. Individuals and relatives portrayed
in the photos have provided written consent for reproduction.

into poverty. Inequalities amplify the hardships of a pandemic.9 For

tion for educated middle-class workers, but it is out of reach for the

vulnerable populations, quarantine is often an unreachable luxury as

most vulnerable.

they have to work to survive.

Dementia is compromised by intersectional inequalities, including

Social containment measures can have a devastating impact on

socioeconomic factors30 and modifiable risk-related social determi-

LACs’ households. Informal workers represent a significant share of the

nants of health (SDH).31 These factors are stronger determinants

LACs’ workforce. Most have no access to social protection, and almost

of dementia prevalence than race or cultural identifiers,30 are more

no savings to carry them through the pandemic.2 Informal employees

accentuated in LACs,31,32 and will be violently worsened by COVID-

are the first to lose their jobs, while self-employed workers such as

19. Vulnerable and ethnic minorities suffering with dementia often

street sellers and small service providers are left with no source of

receive inadequate care (access to diagnostic testing and medica-

income as streets became empty. Working from home may be a solu-

tions, and near absence of 24-hour care)33 and now will be exposed
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BOX 2—Recommendations for Latin American and Caribbean Countries (LACs)
A. General recommendations
- Coordination and integration of isolated actions to support dementia patients (prevention actions, test development, epidemiologic
measures, awareness of dementia risk, recommendations for dissemination).
B. Specific recommendations
Testing dementia populations
- Dementia patient inclusion in priority lists allowing widespread point-of-service testing will permit contact tracing and containment
for those who test positive.
- Massive testing in LACs for priority populations including people living with dementia with allow innovative solutions (scalable
technologies with low-cost instrumentation, non-specialized training, and available reagent supply chain).
Boosting regional coordination to actively engage in global response
- Coordination between available standards (i.e., Organization for Economic Co-operation and Development Policy Response to
COVID-19, G20’s large-scale coordination) and regional non-governmental organizations (NGOs).
- Networking between interregional agencies and multicentric research and interventions.
- Action-to-knowledge framework to prioritize most vulnerable dementia patients.
- Developing essential care required for dementia patients in different contexts considering the vast heterogeneity across LACs.
C. Brain health diplomacy actions
- Brain health diplomacy must build international partnerships to improve dementia care at micro- (individual), meso- (community),
and macro- (national and transnational) levels.
- Multiregional NGOs focused on dementia (Alzheimer’s Association, Alzheimer’s Disease International, the Global Brain Health
Institute), in partnership with local institutions must coordinate a leadership action plan.

to new constraints. With the anticipated poverty increase, most SDH

mechanisms, as well as transition to tailored levels of telemedicine

will worsen. Coronavirus-related burnout syndrome, mental health

and serve as a model for cooperation throughout LACs (see Box 2 for

risks, and patient mistreatment28 will be accentuated by new eco-

the actionable recommendations proposed in this paper). We assess

nomic inequalities. Among the more vulnerable, for example, Venezue-

two main actions requiring urgent response: testing and regional

lan refugees (with 8000% increase) have no guaranteed access to

coordination. These actions are critical to avoid a long delay in the

health and social services.34 Similarly, the pandemic is already spread-

required actions toward public policy changes for dementia in LACs.14

ing across the LACs’ rural indigenous

communities,35

which includes

42 million people in the region who are typically exposed to large
inequalities.36 Indigenous peoples suffer from early onset dementia
and elevated mortality rate, with greater vulnerability to cognitive

4.1
Toward massive testing to assess dementia
populations

disorders.37 In Brazil, the coronavirus-related indigenous death toll
rate is double that of the general population.36 These people are them-

Strategies adopted elsewhere in the world as “flatten the curve” cer-

selves invisible in most the health statistics. But dementia patients

tainly apply to LACs and dementia populations, but the challenges of

from these vulnerable populations are even less visible36 during the

implementation of quarantine and social isolation are far greater. Along

pandemic.

with these measures we need widespread point-of-service testing, contact tracing, and containment for those who test positive. How to
implement a program of mitigation followed by containment is an enor-

4
AN URGENT CALL FOR A COLLABORATIVE
ACTION PLAN

mous challenge and even greater challenge for elders especially those
with dementia across LACs. In particular, the combination of socioeconomic constraints and patient conditions will make general quarantine

The rise of SARS-CoV-2 pandemic creates an uncharted scenario that

unsustainable for the region in the long term. Therefore, we need reli-

will undoubtedly impact LACs’ long-term responses to dementia, even

able, massive, and efficient testing. Moreover, testing programs need to

in the post-pandemic era. A LACs taskforce on dementia may help to

consider LTC facilities as a priority sector.

articulate prevention actions, implement inexpensive SARS-CoV-2 test

Any global action plan requires massive testing.38,39 Given the

development, improve epidemiologic measures, increase awareness of

current limited testing capacity, the current diagnosis strategies are

atypical SARS-Cov-2 in people with dementia, identify best practices

mainly restricted to priority lists (hospitalized patients and health care,

in underserved populations, offer information about dissemination

aging, and underlying conditions, among others),40 thereby reducing
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F I G U R E 2 Cas13-based methods and detection of SARS-CoV-2 RNA using Cas13-based, Rugged, Equitable, Scalable Testing (CREST). A,
Overview of Cas13-based detection methods and CREST modifications: (i–iii) Standard sample collection, RNA extraction, and reverse
transcription. (iv) Amplification using cost-effective Taq polymerase and portable thermocyclers instead of isothermal reactions. (v) Transcription
and Cas13 activation are followed by visualization with blue LED (∼495 nm) and orange filter. B, Detection of SARS-CoV-2 RNA using CREST. The
miniPCR mini16 thermocycler and P51 molecular fluorescence visualizer used in this study. Both are portable, can be operated with batteries, and
have minimal footprint. C, Fluorescence visualization of N1, N2, and N3 synthetic targets using P51 visualizer. Reproduced with authorization
from Rauch et al.41

the availability of massive testing among dementia patients. Testing

Polymerase Chain Reaction (RTqPCR) with a throat or nasal swab.

for dementia patients will help the entire population because they

Unfortunately, RTqPCR is limited, especially in underserved regions

represent a significant number of patients with severe complications

due to expensive reagents, a constricted supply chain, specialized

requiring intensive health support. The percentage of dementia

instrumentation, and trained personnel. In comparison, CRISPR-based

patients being infected appears to be high. According to the World

detection allows scalable, non-specialized performance and a more

Health Organization (WHO), COVID-19 mortality data in people with

available reagent supply chain. Several of the authors (MZW, KSK, DA-

dementia is elevated, with most of COVID-19 deaths coming from LTC

A, CA) have developed such a test called CREST (Cas13-based, Rugged,

(two thirds of people in LTC have dementia); and is estimated that 75%

Equitable, Scalable Testing41 ). CREST pairs commonplace and reliable

of all COVID-19 care home deaths are people with dementia.

biochemical methods (PCR) with low-cost instrumentation, without

Massive testing in LACs for priority populations including dementia

sacrificing detection sensitivity (Figure 2). CREST uses fluorescence

needs innovative actions. A variety of testing approaches exist. These

visualizers for a quick binary interpretation of results, and provides

include direct testing for the viral genome which in the cases of SARS-

a scalable sample collection (laboratory-made viral transport media,

Cov2 is an RNA, testing for the viral protein called the antigen and

3D-printed swabs) that is highly sensitive and requires minimal infras-

testing for immune response to the virus, which involves detection of

tructure. Results can be provided with Bluetooth-enabled thermocy-

the antibodies. These tests provide different types of information. For

clers that run using mobile device applications, combined with simple

example, detection of the viral genome indicates active infection even

light-emitting diode (LED) visualizers, and uploaded with a smart-

if the person is asymptomatic and detection of antibodies indicates a

phone camera. CREST can provide a point-of-care solution to increase

history of infection. Most of the current emphasis is on testing for the

COVID-19 surveillance and diagnostic testing. The same group has

presence of the viral genome sequences using Reverse Transcription-

also reported a field-deployable RNA-extraction procedure called
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PEARL.42 Use of the test in Ecuador is currently under way. Similarly,

future pandemic scenarios.46 The OECD Policy Response to COVID

a laboratory in Brazil has developed a SARS-CoV-2 detection method

pointed to the complex, nested, interconnected systems needed to

in saliva, using RT-LAMP (loop mediated isothermal amplification),43

deliver solutions.47 The G20 countries have called for large-scale coor-

which is also scalable and relatively inexpensive. Researchers from

dination and science- based global response to overcome the pan-

Havana’s Immunoassay Center (CIE) designed a diagnostic test that

demic. Solidarity is a key component for action. Clinical trials and

uses the enzyme linked immunosorbent assay (ELISA) technique, which

subsidies must be coordinated and based on knowledge and solution

identifies small particles and germs that cause disease, and is based on

sharing.48 The European Parliament has requested that EU-funded

ultramicroanalytic (SUMA) technology. Argentina is also developing

medical technologies should be made available, accessible, and afford-

potential massive testing kits, including CRISPR-based detection

able. The SOLIDARITY trial (ISRCTN83971151) is a large global study

approaches.44 In the future, these affordable and non-technically

(45 countries to date) to provide estimations of safety and efficacy

demanding tests may be combined via machine learning with clinical

of treatments that will allow stressed hospitals to participate. Small

symptoms, exposure history, and clinical imaging (chest tomography)

and non-coordinated trials are considered unethical under the current

to improve diagnosis.45 However, alternative testing strategies are not

circumstances.48 Networking has become crucial for developing global

without limitations, in particular test sensitivity involving both false

advances. Different interregional agencies (Horizon 2020, the National

positive and false negative rates. Similar limitations of local technology

Institutes of Health, US Department of Defense) have facilitated mul-

availability call for additional cooperation, pondering the procedures

ticentric research and interventions. Overburdened global health sys-

with less time to obtain test results. Human recourses (delivered

tems can be supported by free and open source scientific and medical

by health-care systems and dementia-related non-governmental

hardware (FOSH).49 FOSH works through a united global community

organizations [NGOs]) are critical for providing local logistics for test

and constitutes a key strategy highlighted in the 2019 Novel Coron-

administration.

avirus Global Research and Innovation Forum. Similarly, collaborative

The current testing capacity for coronavirus across LACs is lim-

responses such as the High Performance Computing Consortium, or

ited, and an established infrastructure for diagnostic and laboratory

the Coronavirus Census Collective (an open-access platform that helps

testing is not available in several hospitals and related institutions in

to predict the location of future outbreaks by combining surveys, diag-

the region.9 Affordable and simple massive testing approaches like

nostic results, and geospatial data) are just some examples50 of global

CREST would allow the tracking of people with cognitive impairment

networking. Consistent scientific evidence needs to be verified, com-

and dementia patients who are exposed to higher risks. Early identi-

posed, and evaluated with large-scale efforts.51 Any delay in joining

fication of dementia patients with SARS-CoV-2 will reduce costs and

global actions will worsen the consequences of the pandemic.

mortality considerably.

More tailored solutions are requested for Latin America. The

Once testing of dementia patients is widely available, the next step

combination of health, political, and economic emergency triggered

is following up with the positive cases. To achieve this, international

by the coronavirus make the regional networks best placed to assess

cooperation is critically need. For instance, the WHO-Alzheimer’s

needs and lead planning, especially in low and middle income countries

Association International Cohort Study of Chronic Sequeale of

(LMIC)52 and LACs.53 Regional coordination should also establish

SARS-CoV-2 (CNS-SARS-CoV-2) has established a global consortium

the priorities for the most vulnerable and orchestrate compensatory

to longitudinally assess individuals and characterize neurological and

actions for patient suffering. LAC scientists, advocates, and health

neuropsychiatric sequalae. As this consortium includes dementia

policymakers need to be included as equal partners in the global plans.

patients, and several LACs are part of the initiative, the outcomes

This will allow the efficient distribution of global resources, as is the

of this project will be relevant for the region. In particular, the CNS-

case of support from the Asia-PAHO collaboration for the general

SARS-CoV-2 initiative will provide a clearer picture of the role of

population of Latin America.9 Strategies for developing essential

viral infections on cognitive decline and dementia risk, and their

care required for dementia patients in different contexts should be

impact in symptom development (eg, loss of smell/taste, seizures,

identified at regional bases. As Latin America became a hot spot

stroke, delirium, etc.). The study of genetic and social determinants of

of the pandemic, the role of its regional initiatives connected with

health risks and their interaction with SARS-CoV-2 may also provide

global responses becomes critical.54 These actions, preliminary and

relevant pathways to understand the impact on the most vulnerable

imperfect, will require coordinated efforts to evolve toward more

dementia patients in the region, as well as other long-term unexplored

equitable solutions.52

consequences of coronavirus–induced cognitive decline and dementia.

4.2
Boosting regional coordination to actively
engage in global responses

4.3
Acknowledging the challenges of
non-homogeneous scenarios across LACs
One important step to deliver an efficient regional action plan con-

The COVID-19 pandemic has become a brain health catastrophe, and

sists in identifying and incorporating the large heterogeneity across

global actions coordinating economic, health, scientific, and technolog-

the region. Latin America is a very heterogeneous region, with

ical actions are required to rebuild living standards and to anticipate

socioeconomic and cultural contrasts, as well as different political,
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health, and diplomacy structures. Homogenizing a vast region with

The Latin American and Caribbean consortium on dementia

widespread diversity will not work. LACs are not uniform, and some

(LAC-CD), has developed a regional action plan for a coordinated

cities with stronger health organization and resources to face demen-

and multilevel response to fight dementia.56 This plan includes a

tia needs (such as Havana, Medellin, Montevideo, Buenos Aires) can

knowledge-to action-framework (KtAF) to deliver coordinative pro-

respond better than others (such as Guayaquil, Manaus, Lima, Iquitos).

grams involving hundreds of local institutions and carry out additional

Even within the same country, this scenario has been highlighted in

triangulation with regional NGOs. The LAC-CD coordinative plan must

Guayaquil, Ecuador where health services were so overwhelmed that

urgently consider additional challenges imposed by the pandemic,2

they were unable to clear the numerous bodies from the street. This sit-

connecting both local initiatives and global dementia strategies (as has

uation contrasts with SARS-CoV-2 cases and mortality in Quito, where

been recently done in dementia care and prevention).

case numbers have been more comparable to other regions. These local
differences may be explained by the acceptance of physical distancing
and the use of masks in the community; however, it would be useful to
survey for local viral strains that may be associated with phenotypic dif-

5
THE ROLE OF NGOs AND BRAIN HEALTH
DIPLOMACY FOR DEMENTIA IN LACs

ferences. Importantly, regional assessments must be conducted down
to the level of municipalities and even more locally to guide remedia-

Regional cooperation and shared experience for dementia can-

tion toward the areas of greatest need. In Peru, Lima is suffering one

not be ignored in this time of crisis. In other regions, coordinated

of the most severe impacts of COVID-19, but Cuzco, a very crowded

plans improved the adequate responses to SARS-CoV-2 in aging

tourist destination at high altitude, has had few deaths.9 Similar differ-

populations.57 Brain health diplomacy58,59 can help build international

ences are also observed between countries in available resources, with

partnerships to improve dementia outcomes for LACs at micro- (indi-

Guatemala and Haiti having less than 200 ventilators between them,24

vidual), meso- (community), and macro- (national and transnational)

but Argentina having more than 10,000.

levels. Large-scale diplomatic action may include efforts to coordinate

Given this heterogeneity, not all initiatives will work well in dif-

lessons learned across other countries; share protocols; and establish

ferent settings. The response to the pandemic is influenced by local,

multi-national agreements for research, advocacy, clinical care, and

regional, national, and global policies and political decisions. Early

public health. By increasing coordination across countries, disciplines,

containment measures in Germany lowered COVID-19 incidence and

and sectors already working on coronavirus and dementia in the region

mortality, but these strategies might not be feasible or could have

can bring novel solutions to current challenges. Brain health diplomacy

unintended consequences in Latin America. Similar positive results

should be led by multiregional NGOs focused on dementia such as the

in some countries within LACs should be extrapolated to others with

Alzheimer’s Association (AA), Alzheimer’s Disease International (ADI),

caution. Cuba, Argentina, and Costa Rica had better management of

or the Global Brain Health Institute (GBHI), in strong partnership with

this unique situation by developing strict enforcement of social dis-

local institutions on the ground that can coordinate a leadership action

tancing and lockdown. In the Caribbean, specific actions for dementia

plan supported by multilateral networking.

include special focus on LTC, developing 24/7 help-lines, assessing
mental health disorders in elders, and providing caregiving training
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